Core Viewpoint - The resumption of the "Military Reclamation · Express Fresh" all-cargo flight route from Shihezi to Nanjing marks a significant development in enhancing logistics and transportation capabilities for Xinjiang products [1] Group 1: Flight Route Details - The all-cargo flight CF9064 operated by China Postal Airlines uses a B737-800 aircraft with a net cargo capacity of 17 tons per flight [1] - The route will operate daily from January 4 to February 12, 2023, ensuring consistent service [1] Group 2: Logistics and Collaboration - Shihezi City is leveraging its dual advantages as a production service logistics hub and a national cold chain logistics base to enhance cooperation with China Postal Group's Xinjiang branch [1] - In the previous year, the route completed 40 flights, achieving a cargo throughput of over 500 tons [1] Group 3: Product Transportation - The flight route serves as a vital air corridor for high-quality products from Xinjiang, including cotton, dairy products, specialty fruits, and beef and lamb, reaching over 60 large and medium-sized cities in the Yangtze River Delta within 5 hours [1] - It also facilitates the entry of high-quality products from outside Xinjiang into the region through the "Air Silk Road" [1]

Core Viewpoint - The company plans to repurchase and cancel a total of 192,720 restricted shares due to unmet performance targets for the fiscal year 2024, which constitutes 37.80% of the total restricted shares granted under the 2023 incentive plan [2][4]. Group 1: Reasons for Repurchase and Cancellation - The repurchase and cancellation of shares are based on the company's failure to meet performance assessment criteria as outlined in the 2023 Restricted Stock Incentive Plan [2][4]. - The company achieved a revenue of 1,359.07 million yuan in 2024, representing a growth rate of 22.69% compared to 2022, but still did not meet the performance targets set for the incentive plan [6]. Group 2: Details of the Repurchase and Cancellation - The repurchase includes 175,920 shares from 26 incentive recipients who did not meet the release conditions, and an additional 16,800 shares from one individual who is no longer eligible due to resignation [2][6]. - The repurchase price is adjusted to 22.60 yuan per share, totaling 4,355,472 yuan, funded by the company's own resources [7]. Group 3: Share Structure Changes - Following the repurchase and cancellation, the total number of shares will decrease from 73,468,201 to 73,275,481 [9]. - The cancellation will not affect the control of the company, and the share distribution will still meet the listing requirements [11]. Group 4: Legal Compliance and Commitments - The company has followed all necessary decision-making procedures and disclosure obligations as per legal regulations and the incentive plan [12]. - The company commits to handling any disputes arising from the repurchase and cancellation process and assumes legal responsibility for the accuracy of the information provided [12].

证券代码：605588 证券简称：冠石科技 公告编号：2026-002 回购注销原因：根据《上市公司股权激励管理办法》《南京冠石科技股 份有限公司 2023 年限制性股票激励计划（草案）》等相关规定，鉴于公司 2024 年度公司层面业绩考核不达标，公司拟回购注销第二个解除限售期激励对象已获 授但不满足解除限售条件的限制性股票 175,920 股；另鉴于获授限制性股票的激 励对象中 1 人因离职已不具备激励对象资格，其已获授但尚未解除限售的 16,800 股限制性股票将由公司回购注销。公司本次拟回购注销部分限制性股票共计 192,720 股，占 2023 年限制性股票激励计划已授予限制性股票总数的 37.80%， 占回购注销前公司股本总额 0.26%。 本次注销股份的有关情况： | 回购股份数量（股） | 注销股份数量（股） | 注销日期 | | | --- | --- | --- | --- | | 192,720 | 192,720 | 年 月 2026 1 | 日 15 | 一、本次限制性股票回购注销的决策与信息披露 1、公司于 2025 年 10 月 24 日召开第二届董事会第二十九次会议和第二届监 事 ...

北京市金杜（南京）律师事务所 关于南京冠石科技股份有限公司 2023年限制性股票激励计划 回购注销部分限制性股票相关事项的 法律意见书 致：南京冠石科技股份有限公司 北京市金杜（南京）律师事务所（以下简称金杜或本所）受南京冠石科技股份有限公 司（以下简称公司或冠石科技）委托，作为公司2023年限制性股票激励计划（以下简称 本次激励计划或本激励计划）的专项法律顾问，根据《中华人民共和国公司法》（以下简 称《公司法》）、《中华人民共和国证券法》（以下简称《证券法》）、中国证券监督管 理委员会（以下简称中国证监会）《上市公司股权激励管理办法（2025修正）》（以下 简称《管理办法》）等法律、行政法规、部门规章及规范性文件（以下简称法律法规）和 《南京冠石科技股份有限公司章程》（以下简称《公司章程》）、《南京冠石科技股份有 限公司2023年限制性股票激励计划（草案）》（以下简称《激励计划（草案）》）的有 关规定，就公司本激励计划部分激励对象已获授但尚未解除限售的限制性股票回购注销 （以下简称本次回购注销）所涉及的相关事项，出具《北京市金杜（南京）律师事务所关 于南京冠石科技股份有限公司2023年限制性股票激励计划回购 ...

Core Viewpoint - The company announced a plan to repurchase and cancel a portion of restricted stock due to not meeting the 2024 performance assessment targets and the departure of one incentive recipient [1] Group 1: Repurchase Details - The board and supervisory board approved the repurchase of 175,920 shares from 26 incentive recipients at a price of 22.60 yuan per share, along with 16,800 shares from the departed employee, totaling 192,720 shares [1] - The company has opened a dedicated repurchase account and applied for the transfer of shares, with the repurchase and cancellation expected to be completed by January 15, 2026 [1] - Subsequent procedures will include capital reduction and share cancellation registration [1]

南京冠石科技股份有限公司（以下简称"公司"）于2026年1月7日收到上海证券交易所（以下简称"上交 所"）出具的《关于受理南京冠石科技股份有限公司沪市主板上市公司发行证券申请的通知》（上证上 审（再融资）〔2026〕4号）。上交所依据相关规定对公司报送的沪市主板上市公司发行证券的募集说 明书及相关申请文件进行了核对，认为该项申请文件齐备，符合法定形式，决定予以受理并依法进行审 核。 公司本次向特定对象发行A股股票事项尚需上交所审核通过及中国证券监督管理委员会（以下简称"中 国证监会"）作出同意注册决定后方可实施，最终能否通过上交所审核，并获得中国证监会同意注册的 决定及其时间尚存在不确定性。公司将根据该事项的进展情况及时履行信息披露义务，敬请广大投资者 注意投资风险。 特此公告。 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：605588 证券简称：冠石科技 公告编号：2026-001 南京冠石科技股份有限公司 关于向特定对象发行A股股票申请获得上海证券交易所受理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责 ...

Group 1 - Jinli Permanent Magnet expects a net profit of 660 million to 760 million yuan for 2025, representing a year-on-year growth of 127% to 161% [1] - Wens Foodstuffs anticipates a net profit of 5 billion to 5.5 billion yuan for 2025, a decrease of 40.73% to 46.12% compared to the previous year [2] - New Open Source plans to repurchase shares worth 40 million to 50 million yuan, with a maximum repurchase price of 25.77 yuan per share [3] Group 2 - Fosun Pharma's subsidiary has had a drug registration application accepted for a new drug targeting ALK-positive non-small cell lung cancer [4] - Leike Film reported a net profit of -86 million yuan for the first three quarters of 2025, indicating a potential annual loss [5] - Crown Stone Technology's application for a specific issuance of A-shares has been accepted by the Shanghai Stock Exchange [6] Group 3 - Dongxin Technology has completed the business registration change for its subsidiary, Lishuan Technology, and has invested 211 million yuan in it [7] - Tianci Materials has increased its commodity futures hedging business limit from 150 million to 300 million yuan [8] - Gaode Infrared's actual controller has reduced his shareholding by 0.54%, bringing his stake down to 62.95% [9] Group 4 - Tianyong Intelligent expects a net profit of 10 million to 15 million yuan for 2025, marking a turnaround from losses [10][11] - China Merchants Energy anticipates a net profit of 6 billion to 6.6 billion yuan for 2025, an increase of 17% to 29% year-on-year [18] - Guangdong Electric Power A's Huizhou Power Plant's Unit 5 has been put into commercial operation, with an investment of 8.05 billion yuan [19] Group 5 - Jianghuai Automobile reported a 42.24% year-on-year increase in sales volume for December 2025 [25] - China Pharmaceutical's subsidiary has received a drug registration certificate for a new medication [26] - TianNeng Co. plans to use up to 12 billion yuan of its own funds for entrusted wealth management [27] Group 6 - Luoyang Huizhong reported a 10.55% month-on-month decrease in sales revenue from live pigs for December 2025 [28] - Baolidi expects a net profit of 145 million to 152 million yuan for 2025, a year-on-year increase of 27.17% to 33.30% [30] - Changchun High-tech's subsidiary has had a melatonin granule registration application accepted [31] Group 7 - Zhongmin Energy reported a 4.46% year-on-year decrease in cumulative on-grid electricity for 2025 [32] - Huaxin Electronics reported a 7.79% year-on-year decrease in consolidated operating revenue for December 2025 [35] - Xiamen Airport reported a 2.79% year-on-year increase in passenger throughput for December 2025 [36] Group 8 - Baiyun Airport reported a 12.27% year-on-year increase in passenger throughput for December 2025 [37] - Pulaike has received a new veterinary drug registration certificate for a chewable tablet [38] - Yunnan Energy Holdings' subsidiary has reduced its stake to 84% after a capital increase [39] Group 9 - Gansu Energy Chemical's new thermal power project has successfully completed trial operation [41] - Zhenghong Technology reported a significant decrease in sales revenue from live pigs for December 2025 [42] - Huasheng Lithium Battery is planning to issue H-shares for listing on the Hong Kong Stock Exchange [43] Group 10 - Jincheng Mining has signed a mining production contract with an estimated total price of approximately 510 million yuan [44] - Microchip Biotech has received approval for clinical trials of a new drug for pancreatic cancer [45] - Yahon Pharmaceutical has completed the first patient enrollment for a Phase I clinical trial of its drug [46]

Core Viewpoint - Guanshi Technology (605588.SH) has received notification from the Shanghai Stock Exchange regarding the acceptance of its application for issuing securities on the Shanghai main board, indicating a step forward in its capital raising efforts [1] Group 1: Company Actions - The company submitted its securities issuance application and related documents to the Shanghai Stock Exchange, which have been verified as complete and compliant with legal requirements [1] - The issuance of A-shares to specific investors is contingent upon approval from the Shanghai Stock Exchange and registration consent from the China Securities Regulatory Commission [1] Group 2: Regulatory Process - The acceptance of the application by the Shanghai Stock Exchange initiates a review process, but the final outcome and timing of the approval from both the exchange and the regulatory commission remain uncertain [1]

南京冠石科技股份有限公司董事会 2026 年 1 月 9 日 证券代码：605588 证券简称：冠石科技 公告编号：2026-001 南京冠石科技股份有限公司 关于向特定对象发行 A 股股票申请 获得上海证券交易所受理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 南京冠石科技股份有限公司（以下简称"公司"）于 2026 年 1 月 7 日收到 上海证券交易所（以下简称"上交所"）出具的《关于受理南京冠石科技股份有 限公司沪市主板上市公司发行证券申请的通知》（上证上审（再融资）〔2026〕 4 号）。上交所依据相关规定对公司报送的沪市主板上市公司发行证券的募集说 明书及相关申请文件进行了核对，认为该项申请文件齐备，符合法定形式，决定 予以受理并依法进行审核。 公司本次向特定对象发行 A 股股票事项尚需上交所审核通过及中国证券监 督管理委员会（以下简称"中国证监会"）作出同意注册决定后方可实施，最终 能否通过上交所审核，并获得中国证监会同意注册的决定及其时间尚存在不确定 性。公司将根据该事项的进展情况及时履行信息披露义务 ...

格隆汇1月8日丨冠石科技(605588.SH)公布，公司于2026年1月7日收到上交所出具的《关于受理南京冠 石科技股份有限公司沪市主板上市公司发行证券申请的通知》(上证上审(再融资)〔2026〕4 号)。上交 所依据相关规定对公司报送的沪市主板上市公司发行证券的募集说明书及相关申请文件进行了核对，认 为该项申请文件齐备，符合法定形式，决定予以受理并依法进行审核。 公司本次向特定对象发行 A 股股票事项尚需上交所审核通过及中国证监会作出同意注册决定后方可实 施，最终能否通过上交所审核，并获得中国证监会同意注册的决定及其时间尚存在不确定性。 ...